Manufacturers Life Insurance Company, The Bei Gene, Ltd. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 57,384 shares of BGNE stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
57,384
Previous 50,262
14.17%
Holding current value
$10.2 Million
Previous $7.17 Million
79.68%
% of portfolio
0.01%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding BGNE
# of Institutions
252Shares Held
45.3MCall Options Held
292KPut Options Held
119K-
Baker Bros. Advisors LP New York, NY10.6MShares$1.88 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.14 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$920 Million26.65% of portfolio
-
Primecap Management CO Pasadena, CA4.97MShares$884 Million0.84% of portfolio
-
Baillie Gifford & CO3.71MShares$659 Million0.64% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $18.4B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...